Variational AI
Rakovina Raises C$1.99M for AI-Designed Cancer Programs
Rakovina Therapeutics Inc. (TSXV: RKV; FSE: 7JO0) has completed an upsized private placement that raised aggregate gross proceeds of C$1.991 million to support its preclinical cancer-drug pipeline. According to the August 31 financing announcement, the company issued 19.91 million units at C$0.10 each across two tranches. Each unit contained one common share and one-half warrant.…
